World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03593252
Date of registration: 22/05/2018
Prospective Registration: Yes
Primary sponsor: McMaster University
Public title: Bowel Preparation in Elective Pediatric Intestinal Surgery
Scientific title: Mechanical Bowel Prep and Prophylactic Oral Antibiotic Use in Children: Implications for Intestinal Surgery Complications
Date of first enrolment: September 1, 2018
Target sample size: 48
Recruitment status: Not yet recruiting
URL:  https://clinicaltrials.gov/show/NCT03593252
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Care Provider, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Contacts
Name:     Tessa Elliott, BHsc, MSc
Address: 
Telephone: 905-521-2100
Email: elliot1@mcmaster.ca
Affiliation: 
Name:     Helene Flageole, MD, MSc, FRCSC, FACS
Address: 
Telephone:
Email:
Affiliation:  McMaster Children's Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients aged six months to eighteen years presenting to the Pediatric General Surgery
service at McMaster Children's Hospital for elective colorectal surgery will be
screened for inclusion in this study.

Exclusion Criteria:

- Mechanical bowel obstruction

- Known hypersensitivity to laxatives or oral antibiotics

- Congestive heart failure

- Renal insufficiency

- Other medical conditions precluding the use of either oral antibiotics or mechanical
bowel preparations



Age minimum: 6 Months
Age maximum: 18 Years
Gender: All
Health Condition(s) or Problem(s) studied
Jejunostomy Stoma
Ileostomy - Stoma
NEC
Bowel Obstruction
Colostomy Stoma
Hirschprung's Disease
Meconium Ileus
Inflammatory Bowel Diseases
Intervention(s)
Drug: Erythromycin
Drug: Senna
Drug: Metronidazole
Drug: Sodium Picosulfate, Magnesium Oxide and Citric Acid
Drug: Cefazolin
Drug: Kanamycin
Other: Nil per os
Primary Outcome(s)
Feasibility [Time Frame: 30 days post-operatively]
Secondary Outcome(s)
anastomotic leak - Surgical site infection (SSI) [Time Frame: 30 days post-operatively.]
Length of hospital stay [Time Frame: 30 days post-operatively.]
Time to full enteric feed. [Time Frame: 30 days post-operatively.]
Re-admission [Time Frame: 30 days post-operatively.]
Clostridium difficile infection [Time Frame: 30 days post-operatively.]
electrolyte disturbance [Time Frame: On day of surgery]
Re-operation [Time Frame: 30 days post-operatively.]
superficial Incisional surgical site infection (SSI) [Time Frame: 30 days post-operatively.]
Organ space - Surgical site infection (SSI) [Time Frame: 30 days post-operatively.]
Deep incisional surgical site infection (SSI) [Time Frame: 30 days post-operatively.]
Secondary ID(s)
Bowel_prep_pediatric_sx
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history